Premature deaths after discharge from methadone maintenance: A replication

Journal of Addiction Medicine

Volumn 1, Issue 4, 2007, Pages 180-185

  Woody, George E ^a,b,c   Kane, Vince ^a   Lewis, Kimberly ^a   Thompson, Richard ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Methadone maintenance; Mortality; Treatment discharge

Indexed keywords

EID: 55549097747     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318155980e     Document Type: Article

References (41)

1. Dole VP, Nyswander ME. A medical treatment for diacetylmorphine (heroin) addiction. JAMA. 1965;193:646-650.
2. Dole VP, Nyswander M. Successful treatment of 750 criminal addicts. J Am Med Assoc. 1968;26:2708-2710.
3. NIH Consensus Statement. Effective Medical Treatment of Opiate Addiction. Rockville: National Institutes of Health; 1997.
4. Schwartz RP, Highfield DA, Jaffe JH, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psych. 2006;63:102-109. (Pubitemid 43037474)
5. Belding MA, Iguchi MY, Lamb RJ, et al. Stages and processes of change among polydrug users in methadone maintenance treatment. Drug Alcohol Depend. 1995:39;45-53.
6. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag, 1991.
7. Caplehorn JRM, Bell J. Methadone dosage and retention of patients in maintenance treatment. Med J Australia. 1991;154:195-199.
8. Iguchi MY, Lamb RJ, Belding MA, et al. Contingent reinforcement of group participation versus abstinence in a methadone maintenance program. Exp Clin Psychopharmacol. 1996;4:315-321. (Pubitemid 26285672)
9. Iguchi MY, Belding MA, Morral AR, et al. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol 1997;65:421-428. (Pubitemid 27246783)
10. Iguchi MY, Handlesman L, Bickel WK, et al. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend. 1993;32:257-266. (Pubitemid 23210345)
11. Sees KL, Delucci KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000;283:1303-1310. (Pubitemid 30129797)
12. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689-1695.
13. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry. 1983;40:639-645. (Pubitemid 13094931)
14. Woody GE, McLellan AT, Luborsky L, et al. Psychotherapy in community methadone programs: a validation study. Am J Psychiatry. 1995;152:1302-1308.
15. Nunes EV, Quitkin FM, Donovan S, et al. Imipramine treatment of opiate dependent patients with depressive disorders: a placebo-controlled trial. Arch Gen Psychiatry. 1998;55:153-160. (Pubitemid 28087601)
16. Stitzer ML, Iguchi MY, Felch L. Contingent take-home incentive: effects on drug use in methadone maintenance patients. J Consult Clin Psychol. 1992;60:927-934.
17. Silverman K, Wong CJ, Higgins ST, et al. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 1996;41:157-165. (Pubitemid 26183908)
18. Dolan MP, Black JL, Penk WE, et al. Contracting for treatment termination to reduce illicit drug use among methadone maintenance treatment failures. J Consult Clin Psychol. 1985;53:549-551. (Pubitemid 15046934)
19. Kidorf M, Brooner RK, King VL. Motivating methadone patients to include drug-free significant others in treatment: a behavioral intervention. J Subst Abuse Treat. 1997;1:23-28. (Pubitemid 27314015)
20. Kidorf M, Neufeld K, Brooner RK. Combining stepped-care approaches with behavioral reinforcement to motivate employment in opioid-dependent outpatients. Subst Use Misuse. 2004;39:2215-2238.
21. Brooner RK, Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Sci Pract Perspect. 2002;1:38-46.
22. Calsyn DA, Wells EA, Saxon AJ, et al. Contingency management of urinalysis results and intensity of treatment have an interactive impact on methadone maintenance treatment outcome. J Addict Dis. 1994;13:47-63.
23. Langendam MW, van Brussel GHA, Coutinho RA, et al. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Pub Health. 2001;91:774-780. (Pubitemid 32397914)
24. Digiusto E, Shakesshaft A, Ritter A, et al. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for opioid dependence (NEPOD). Soc Study Addict. 2004;99:450-460. (Pubitemid 38496661)
25. Esteban J, Gimeno C, Barril J, et al. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug Alcohol Depend. 2003;70:193-200. (Pubitemid 37034172)
26. Caplehorn JRM, Dalton MS, Cluff MC, Petrenas A. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994;89:203-207.
27. Caplehorn JR, Dalton MS, Haldar F, et al. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse. 1996;31:177-196. (Pubitemid 26094982)
28. Darke S, Ross J, Zador D, et al. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend. 2000;60:141-151.
29. Fugelstad A, Annell A, Rajs J, et al. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992. Acta Psychiatrica Scand. 1997;96:169-175. (Pubitemid 27368454)
30. Gearing FR, Schweitzer MD. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am J Epidemiol. 1974;100:102-112.
31. Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatrica Scand. 1990;82:223-227. (Pubitemid 20329007)
32. Tyndall MW, Craib KJ, Currie S, et al. Impact of HIV infection on mortality in a cohort of injection drug users. J Acquir Immune Defic Syndr. 2001;28;351-357. (Pubitemid 33101288)
33. van Ameijden EJC, Langendam MW, Coutinho RA. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold methadone maintenance programs. Addict Behav. 1999; 24:559-563. (Pubitemid 29342933)
34. Zanis DA, Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend. 1998;52:257-260. (Pubitemid 28529584)
35. Calsyn DA, Saxon AJ, Barndt CD. Urine screening practices in methadone maintenance clinics: a survey of how results are utilized. J Nerv Ment Dis. 1991;179:222-227.
36. McLellan AT, Luborsky L, O'Brien CP, et al. Improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33. (Pubitemid 10187569)
37. McLellan AT, Alterman AI, Woody GE, et al. A quantitative measure of substance abuse treatments: the Treatment Services Review. J Nerv Ment Dis. 1992;180:100-109.
38. Woody GE, McLellan AT. Continuing drug use by methadone patients: high vs lower dose and MET vs DC. Presented at annual meeting of College on Problems of Drug Dependence, 2001.
39. Calsyn DA, DeMarco FJ, Saxon AJ, et al. Evaluation of a minimal services track for noncompliant patients in opioid substitution treatment. Am J Pub Health. 2003;93:1086-1088. (Pubitemid 38489776)
40. Gottheil E, Sterling RC, Weinstein SP. Diminished illicit substance abuse as a consequence of long-term methadone maintenance. J Addict Dis. 1993;12 45-57. (Pubitemid 24007538)
41. Weinstein SP, Gottheil E, Sterling RC, et al. Long-term methadone maintenance treatment: some clinical examples. J Subst Abuse Treat. 1993;10:277-281. (Pubitemid 23174673)